본문내용 바로가기
KOLON Biotech has more than
20 years of experiences
in the cell and gene therapy.

History

history
  • 2000
    Established TissueGene Asia Ltd. in Korea
  • 2006
    Changed the company name to Kolon Life Science, Inc.
  • 2009
    IPO (Korea, KOSDAQ)
  • 2014
    Constructed Bio Plant B1
  • 2017
    Started commercial manufacturing of cell and gene therapy products
  • 2019
    Completed Bio cGMP (planned) Plant B2
  • 2020
    Split off KOLON Life Science to KOLON Biotech

Location

Seoul
KOLON One & Only Tower, 110, Magokdong-ro, Gangseo-gu, Seoul, Republic of Korea
KOLON One & Only Tower, 110, Magokdong-ro, Gangseo-gu, Seoul, Republic of Korea
Chungju
[Plant] 54-1, Gieopdosi 1-ro, Daesowon-myeon, Chungju-si, Chungcheongbuk-do, Republic of Korea
[Plant] 54-1, Gieopdosi 1-ro, Daesowon-myeon, Chungju-si, Chungcheongbuk-do, Republic of Korea

Brochure

brochure brochure
2022
KOLON Biotech CDMO flyer
Download

Highly-
Skilled Teams

We have CDMO employees with extensive experiences in analytical, formulation, manufacturing and regulatory activities in the biopharmaceutical area. We maintain a diverse workforce mix for each function.
Highly-Skilled Teams
TOP